On January 16, 2018, Tissue Analytics, Inc. closed the transaction. The company received its series A round of funding from 12 investors led by new investor DigiTx Partners. The transaction also included participation from existing investors Tencent Holdings Limited (SEHK:700), Mölnlycke Health Care AB, DreamIt and new investors Clinical Care Associates Of The University Of Pennsylvania Health System and Intermountain Healthcare, Inc.